$206.15
-0.14-0.07%
Benzinga
Benzinga
Benzinga
화요일, 10월 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Nutex Health (NUTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Nutex Health (NUTX)는 8월 14, 2025에 Q2 2025에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $244M - $244M 범위로 예상했습니다.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.03 | $5.56 | $5.56 | $1.95 |
| Actual | $9.38 | $6.52 | $1.61 | $7.76 |
| Surprise | +86.5% | +17.3% | -71.0% | +297.9% |
| Revenue | ||||
| Estimate | $216.0M | $227.8M | $258.8M | $213.8M |
| Actual | $210.8M | $216.5M | $151.7M | $267.8M |
| Surprise | -2.44% | -4.97% | -41.4% | +25.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $5.67 | $6.20 | $7.57 | $6.86 |
| Revenue | ||||
| Consensus | $215.4M | $229.6M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $9.38 | $5.03 | 86.5 % |
| Q1 | Apr 30, 2026 | $6.52 | $5.56 | 17.3 % |
| Q4 | Mar 5, 2026 | $1.61 | $5.56 | -71.0 % |
| Q3 | Nov 19, 2025 | $7.76 | $1.95 | 297.9 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $210.75M | $216.02M | -2.44 % |
| Q1 | Apr 30, 2026 | $216.49M | $227.80M | -4.97 % |
| Q4 | Mar 5, 2026 | $151.68M | $258.82M | -41.4 % |
| Q3 | Nov 19, 2025 | $267.80M | $213.81M | 25.3 % |